Sign in

CIK 0000920148

  • Large accelerated filer

LABCORP HOLDINGS INC.

Sign in to watch
Ticker
LH
Exchange
NYSE
Industry
Services-Medical Laboratories
FY end
Dec 31
Entity type
Operating
EIN
992588107
Phone
+1 336-229-1127
Business address
358 S MAIN ST, BURLINGTON, NC, 27215
Former names
LABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,241,708
in 3 filings, $108K under 10b5-1 plans

Net −$1,241,708. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-03-27 Schechter Adam H President & CEO Grant or award +30,469 118,651
2025-03-27 Schechter Adam H President & CEO Shares withheld for taxes −13,584 $231.67 $3.1M 105,067
2025-03-27 EISENBERG GLENN A Executive Vice President Grant or award +8,305 41,550
2025-03-27 EISENBERG GLENN A Executive Vice President Shares withheld for taxes −3,630 $231.67 $841K 37,920
2025-03-27 BERBERIAN LANCE EVP, Special Advisor, Strategy Grant or award +3,325 20,005
2025-03-27 BERBERIAN LANCE EVP, Special Advisor, Strategy Shares withheld for taxes −1,353 $231.67 $313K 18,652
2025-03-27 Caveney Brian J EVP, Pres of ED, CMO & CSO Grant or award +4,840 34,175.66
2025-03-27 Caveney Brian J EVP, Pres of ED, CMO & CSO Shares withheld for taxes −2,109 $231.67 $489K 32,066.66
2025-03-27 Wilkinson Peter J SVP, Chief Accounting Officer Grant or award +1,249 3,242.22
2025-03-27 Wilkinson Peter J SVP, Chief Accounting Officer Shares withheld for taxes −359 $231.67 $83K 2,883.22
2025-03-27 Oyegunwa Akinbolade EVP, CIO & CTO Grant or award +688 3,662.25
2025-03-27 Oyegunwa Akinbolade EVP, CIO & CTO Shares withheld for taxes −198 $231.67 $46K 3,464.25
2025-03-05 ANDERSON KERRII B Director Sale −500 $255.63 $128K 13,166
2025-02-28 Schroeder Mark S EVP, Pres Diagnostics & COO Option exercise 10b5-1 +3,903 $131.43 $513K 10,299.14
2025-02-28 Schroeder Mark S EVP, Pres Diagnostics & COO Sale 10b5-1 −5,339 $249.23 $1.3M 4,960.14
2025-02-28 Schroeder Mark S EVP, Pres Diagnostics & COO Option exercise · Non-qualified Stock Options 10b5-1 −3,903 0
2025-02-25 van der Vaart Sandra D EVP, Chief Legal Officer Sale −1,314 $251.30 $330K 2,170.54
2025-02-24 Summy Amy B. EVP, Chief Marketing Officer Sale 10b5-1 −226 $250.40 $57K 4,544.5
2025-02-18 Wilkinson Peter J SVP, Chief Accounting Officer Option exercise +1,413 $163.63 $231K 3,406.22
2025-02-18 Wilkinson Peter J SVP, Chief Accounting Officer Sale −1,413 $246.10 $348K 1,993.22

Page 15 of 28 · 545 trades